Last updated September 2023 - Microbiology and Molecular Genetics
(1) Klein BY, Greenblatt CL, Gofrit ON, Bercovier H. Bacillus Calmette–Guérin in Immuno-Regulation of Alzheimer’s Disease. Front Aging Neurosci 2022;14.
(2) Dow CT, Greenblatt CL, Chan ED, Dow JF. Evaluation of BCG Vaccination and Plasma Amyloid: A Prospective, Pilot Study with Implications for Alzheimer’s Disease. Microorg 2022;10(2).
(3) Greenblatt CL, Bercovier H, Klein BY, Gofrit ON. Adult Vaccination, Getting to Know Their Nonspecific Effects. J Gerontol Ser A Biol Sci Med Sci 2021;76(10):E235-E236.
(4) Klinger D, Hill BL, Barda N, Halperin E, Gofrit ON, Greenblatt CL, et al. Bladder cancer immunotherapy by BCG Is associated with a significantly reduced risk of Alzheimer’s disease and Parkinson’s disease. Vaccines 2021;9(5).
(5) Mafi M, Kushmaro A, Greenblatt C, Agarwal S, Greiner A. Poly(Vinyl Alcohol)-Hydrogel Microparticles with Soft Barrier Shell for the Encapsulation of Micrococcus luteus. Macromol Biosci 2021;21(5).
(6) Gofrit ON, Klein BY, Cohen IR, Ben-Hur T, Greenblatt CL, Bercovier H. Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients. PLoS ONE 2019;14(11).
(7) Marais BJ, Buddle BM, de Klerk-Lorist L-, Nguipdop-Djomo P, Quinn F, Greenblatt C. BCG vaccination for bovine tuberculosis; conclusions from the Jerusalem One Health workshop. Transboundary Emer Dis 2019;66(2):1037-1043.
(8) Gofrit ON, Bercovier H, Klein BY, Cohen IR, Ben-Hur T, Greenblatt CL. Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer's disease? Med Hypotheses 2019;123:95-97.
(9) Letnik I, Avrahami R, Port R, Greiner A, Zussman E, Rokem JS, et al. Biosorption of copper from aqueous environments by Micrococcus luteus in cell suspension and when encapsulated. Int Biodeterior Biodegrad 2017;116:64-72.
(10) Letnik I, Avrahami R, Rokem JS, Greiner A, Zussman E, Greenblatt C. Living Composites of Electrospun Yeast Cells for Bioremediation and Ethanol Production. Biomacromolecules 2015;16(10):3322-3328.
(11) Der Sarkissian C, Ermini L, Schubert M, Yang MA, Librado P, Fumagalli M, et al. Evolutionary genomics and conservation of the endangered Przewalski's horse. Curr Biol 2015;25(19):2577-2583.
(12) Knierim C, Enzeroth M, Kaiser P, Dams C, Nette D, Seubert A, et al. Living Composites of Bacteria and Polymers as Biomimetic Films for Metal Sequestration and Bioremediation. Macromol Biosci 2015;15(8):1052-1059.
(13) Spigelman M, Donoghue HD, Abdeen Z, Ereqat S, Sarie I, Greenblatt CL, et al. Evolutionary changes in the genome of Mycobacterium tuberculosis and the human genome from 9000 years BP until modern times. Tuberculosis 2015;95(S1):S145-S149.
(14) Knierim C, Greenblatt CL, Agarwal S, Greiner A. Blocked bacteria escape by ATRP grafting of a PMMA shell on PVA microparticles. Macromol Biosci 2014;14(4):537-545.
(15) Ereqat S, Bar-Gal GK, Nasereddin A, Azmi K, Eshtaieh I, Greenblatt CL, et al. Simultaneous detection of Mycobacterium bovis and M. tuberculosis in an apparently immunocompetent patient. Int J Tuberc Lung Dis 2013;17(9):1242-1243.
(16) Ereqat S, Nasereddin A, Levine H, Azmi K, Al-Jawabreh A, Greenblatt CL, et al. First-time detection of Mycobacterium bovis in livestock tissues and milk in the West Bank, Palestinian Territories. PLoS Negl Trop Dis 2013;7(9).
(17) Lee OY-, Wu HHT, Donoghue HD, Spigelman M, Greenblatt CL, Bull ID, et al. Mycobacterium tuberculosis complex lipid virulence factors preserved in the 17,000-year-old skeleton of an extinct bison, bison antiquus. PLoS ONE 2012;7(7).
(18) Ereqat S, Nasereddin A, Azmi K, Abdeen Z, Greenblatt CL, Spigelman M, et al. Genetic characterization of Mycobacterium tuberculosis in the West Bank, Palestinian Territories. BMC Res Notes 2012;5.
(19) Ereqat S, Bar-Gal GK, Nasereddin A, Said S, Greenblatt CL, Azmi K, et al. Pulmonary tuberculosis in the West Bank, Palestinian Authority: Molecular diagnostic approach. Trop Med Int Health 2011;16(3):360-367.
(20) Ereqat S, Bar-Gal GK, Nasereddin A, Azmi K, Qaddomi SE, Greenblatt CL, et al. Rapid differentiation of Mycobacterium tuberculosis and M. bovis by high-resolution melt curve analysis (Journal of Clinical Microbiology (2010) 48, 11, (4269-4672)). J Clin Microbiol 2011;49(2):768.
(21) Ereqat S, Bar-Gal GK, Nasereddin A, Azmi K, Qaddomi SE, Greenblatt CL, et al. Rapid differentiation of Mycobacterium tuberculosis and M. bovis by high-resolution melt curve analysis. J Clin Microbiol 2010;48(11):4269-4272.
(22) Young M, Artsatbanov V, Beller HR, Chandra G, Chater KF, Dover LG, et al. Genome sequence of the fleming strain of Micrococcus luteus, a simple free-living actinobacterium. J Bacteriol 2010;192(3):841-860.
(23) Bar-Gal GK, Rosenberg T, Greenblatt C. Animal remains from Khirbet Qumran: A case study of two bones (qum 392 and 393) from two bone burials. Stud Texts Desert Judah 2010;87:67-75.
(24) Koltunov V, Greenblatt CL, Goncharenko AV, Demina GR, Klein BY, Young M, et al. Structural changes and cellular localization of resuscitation-promoting factor in environmental isolates of Micrococcus luteus. Microb Ecol 2010;59(2):296-310.
(25) Matheson CD, Vernon KK, Lahti A, Fratpietro R, Spigelman M, Gibson S, et al. Molecular exploration of the first-century tomb of the shroud in Akeldama, Jerusalem. PLoS ONE 2009;4(12).
(26) Donoghue HD, Hershkovitz I, Minnikin DE, Besra GS, Lee OY-, Galili E, et al. Biomolecular archaeology of ancient tuberculosis: response to "Deficiencies and challenges in the study of ancient tuberculosis DNA" by Wilbur et al. (2009). J Archaeol Sci 2009;36(12):2797-2804.
(27) Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY-, Gernaey AM, et al. Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a neolithic settlement in the Eastern mediterranean. PLoS ONE 2008;3(10).
(28) Lemma E, Zimhony O, Greenblatt CL, Koltunov V, Zylber MI, Vernon K, et al. Attempts to revive Mycobacterium tuberculosis from 300-year-old human mummies. FEMS Microbiol Lett 2008;283(1):54-61.
(29) Klein BY, Ben-Yair C, Bar-Gal GK, Greenblatt CL. Microsatellite genotyping of cultivars of the Holy Land grapevine, Vitis vinifera ssp. sativa (Vitaceae). Bot J Linn Soc 2008;156(4):513-521.
(30) Zeiman E, Greenblatt CL, Elgavish S, Khozin-Goldberg I, Golenser J. Mode of action of fenarimol against Leishmania spp. J Parasitol 2008;94(1):280-286.
(31) Matheson CD, Muller GC, Junnila A, Vernon K, Hausmann A, Miller MA, et al. A PCR method for detection of plant meals from the guts of insects. Org Diversity Evol 2008;7(4):294-303.
(32) Faerman M, Bar-Gal GK, Hershkovitz I, Spigelman M, Greenblatt CL. Molecular archaeology: People, animals, and plants of the holy land. Isr J Earth Sci 2007;56(2-4):217-230.
(33) Zink AR, Spigelman M, Schraut B, Greenblatt CL, Nerlich AG, Donoghue HD. Leishmaniasis in ancient Egypt and Upper Nubia [10]. Emerg Infect Dis 2006;12(10):1616-1617.
(34) Bader KA, Schnur LF, Nasereddin A, Pratlong F, Dedet J-, Shaheen L, et al. Palestinian infantile visceral leishmaniasis caused by a genetic variant of Leishmania infantum belonging to a new zymodeme. Trop Med Int Health 2005;10(6):618-620.
(35) Donoghue HD, Marcsik A, Matheson C, Vernon K, Nuorala E, Molto JE, et al. Co-infection of Mycobacterium tuberculosis and Mycobacterium leprae in human archaeological samples: A possible explanation for the historical decline of leprosy. Proc R Soc B Biol Sci 2005;272(1561):389-394.
(36) Elfari M, Schnur LF, Strelkova MV, Eisenberger CL, Jacobson RL, Greenblatt CL, et al. Genetic and biological diversity among populations of Leishmania major from Central Asia, the Middle East and Africa. Microbes Infect 2005;7(1):93-103.
(37) Donoghue HD, Spigelman M, Greenblatt CL, Lev-Maor G, Kahila Bar-Gal G, Matheson C, et al. Tuberculosis: From prehistory to Robert Koch, as revealed by ancient DNA. Lancet Infect Dis 2004;4(9):584-592.
(38) Greenblatt CL, Baum J, Klein BY, Nachshon S, Koltunov V, Cano RJ. Micrococcus luteus - Survival in amber. Microb Ecol 2004;48(1):120-127.
(39) Greenblatt C, Spigelman M, Vernon K. The impact of "ancient pathogen" studies on the practice of public health. Public Health Rev 2003;31(2):81-91.
(40) Spigelman M, Matheson C, Lev G, Greenblatt C, Donoghue HD. Confirmation of the Presence of Mycobacterium tuberculosis Complex-Specific DNA in Three Archaeological Specimens. Int J Osteoarchaeol 2002;12(6):393-401.
(41) Bar-Gal GK, Smith P, Tchernov E, Greenblatt C, Ducos P, Gardeisen A, et al. Genetic evidence for the origin of the agrimi goat (Capra aegagrus cretica). J Zool 2002;256(3):369-377.
(42) Anders G, Eisenberger CL, Jonas F, Greenblatt CL. Distinguishing Leishmania tropica and Leishmania major in the Middle East using the polymerase chain reaction with kinetoplast DNA-specific primers. Trans R Soc Trop Med Hyg 2002;96(SUPPL. 1):S1/87-S1/92.
(43) Greenblatt CL, Schnur LF, Bar-Gal GK, Ermolaev H, Peleg N, Barrett MP. Polymorphism among alleles of the 6-Phosphogluconate dehydrogenase gene from Leishmania major and Leishmania tropica. Mol Biochem Parasitol 2002;125(1-2):185-188.
(44) Abdeen ZA, Sawalha SS, Eisenberger CL, Khanfar HM, Greenblatt CL, Yousef O, et al. Epidemiology of visceral leishmaniasis in the Jenin district, West Bank: 1989-1998. Am J Trop Med Hyg 2002;66(4):329-333.
(45) Vitale K, Sahin U, Greenblatt C. The animal and human prion diseases: Public health importance and risk assessment. Period Biol 2001;103(3):201-217.
(46) Rothschild BM, Martin LD, Lev G, Bercovier H, Bar-Gal GK, Greenblatt C, et al. Mycobacterium tuberculosis complex DNA from an extinct bison dated 17,000 years before the present. Clin Infect Dis 2001;33(3):305-311.
(47) Greenblatt CL, Davis A, Clement BG, Kitts CL, Cox T, Cano RJ. Diversity of microorganisms isolated from amber. Microb Ecol 1999;38(1):58-68.
(48) Faerman M, Kahila G, Filon D, Greenblatt CL, Stager L, Oppenheim A, et al. Determining the sex of infanticide victims from the late roman era through ancient DNA analysis. J Archaeol Sci 1998;25(9):861-865.
(49) Faerman M, Kahila G, Smith P, Greenblatt C, Stager L, Filon D, et al. DNA analysis reveals the sex of infanticide victims [3] (multiple letters). Nature 1997;385(6613):212-213.
(50) Greenblatt C. Visceral leishmaniasis--an emerging zoonosis in the Jersalem area. Isr J Med Sci 1996;32(5):338.
(51) Frankenburg S, Axelrod O, Kutner S, Greenblatt CL, Klaus SN, Pirak EA, et al. Effective immunization of mice against cutaneous leishmaniasis using an intrinsically adjuvanted synthetic lipopeptide vaccine. Vaccine 1996;14(9):923-929.
(52) Faerman M, Filon D, Kahila G, Greenblatt CL, Smith P, Oppenheim A. Sex identification of archaeological human remains based on amplification of the X and Y amelogenin alleles. Gene 1995;167(1-2):327-332.
(53) Schenker II, Greenblatt CL. Israeli youth and AIDS: Knowledge and attitude changes among high school students following an AIDS education program. Isr J Med Sci 1993;29(10 SUPPL.):41-47.
(54) Greenblatt CL, Schnur LF, Juster R, Sulitzeanu A. Clonal heterogeneity in populations of Leishmania major. Isr J Med Sci 1990;26(3):129-135.
(55) Giladi M, Danon YL, Greenblatt CL, Block C, Schinder E. Local environmental risk factors in the acquisition of cutaneous leishmaniasis. Isr J Med Sci 1988;24(3):185-187.
(56) Greenblatt CL. Cutaneous leishmaniasis: The prospects for a killed vaccine. Parasitol Today 1988;4(2):53-54.
(57) Rosen G, Londner MV, Sevlever D, Greenblatt CL. Leishmania major: glycolipid antigens recognized by immune human sera. Mol Biochem Parasitol 1988;27(1):93-99.
(58) Schlein Y, Borut S, Greenblatt CL. Development of sandfly forms of Leishmania major in sucrose solutions. J Parasitol 1987;73(4):797-805.
(59) Greenblatt C, el-On J. Leishmaniases: new research findings and their implications in therapy and control. Chemioterapia 1987;6(2 Suppl):350-352.
(60) Shkap V, Pipano E, Greenblatt C. Cultivation of Besnoitia besnoiti and evaluation of susceptibility of laboratory animals to cultured parasites. Vet Parasitol 1987;23(3-4):169-178.
(61) Grossman Z, Greenblatt CL, Cohen IR. Parasite immunology and lymphocyte population dynamics. J Theor Biol 1986;121(2):129-139.
(62) Rosen G, Londner MV, Greenblatt CL, Morsy TA, El-On J. Leishmania major: Solid phase radioimmunoassay for antibody detection in human cutaneous leishmaniasis. Exp Parasitol 1986;62(1):79-84.
(63) Giladi M, Danon YL, Greenblatt C, Schinder E, Nili E. Keziot - a new endemic site of cutaneous Leishmaniasis in Israel. An epidemiological and clinical study of a non-immune population entering an endemic area. Trop Geogr Med 1985;37(4):298-303.
(64) Millgram MA, Greenblatt CL, Shlomai J. Interaction of aminoglycosides and ionophores in the killing of Crithidia fasciculata. Z Parasitenkd 1985;71(6):699-704.
(65) Greenblatt CL, Handman E, Mitchell GF, Battye FL, Schnur LF, Snary D. Phenotypic diversity of cloned lines of Leishmania major promastigotes. Z Parasitenkd 1985;71(2):141-157.
(66) Pritchard DG, Volanakis JE, Slutsky GM, Greenblatt CL. C-Reactive Protein Binds Leishmanial Excreted Factors. Proc Soc Exp Biol Med 1985;178(3):500-503.
(67) Slutzky GM, Londner MV, Greenblatt CL. Lipid and Lipopolysaccharide‐Like Antigens of Leishmania Promastigotes. J Protozool 1985;32(2):347-352.
(68) Shkap V, Ungar-Waron H, Pipano E, Greenblatt C. Specific antibodies to Besnoitia besnoiti precipitated from serum of cattle by live parasites and by soluble antigen. Vet Immunol Immunopathol 1985;9(1):53-57.
(69) Giladi M, Greenblatt C, Schinder E, Danon Y, Nili E. Endemic focus of cutaneous leishmaniasis in Qezi'ot. Harefuah 1984;107(3-4):57-59+112.
(70) Shkap V, Ungar-Waron H, Pipano E, Greenblatt C. Enzyme linked immunosorbent assay for detection of antibodies against Besnoitia besnoiti in cattle. Trop Anim Health Prod 1984;16(4):233-238.
(71) Slutzky GM, Yarus S, Krasner RI, Schnur LF, Greenblatt CL. Leishmanial excreted factors (EF) are distinguished by characteristic electrophoretic mobilities. Z Parasitenkd 1984;70(4):549-551.
(72) El-On J, Jacobs GP, Witztum E, Greenblatt CL. Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals. Antimicrob Agents Chemother 1984;26(5):745-751.
(73) Steinberger A, Slutzky GM, El-On J, Greenblatt CL. Leishmania tropica: Protective response in C3H mice vaccinated with excreted factor crosslinked with the synthetic adjuvant, muramyl dipeptide. Exp Parasitol 1984;58(3):223-229.
(74) Handman E, Greenblatt CL, Goding JW. An amphipathic sulphated glycoconjugate of Leishmania: characterization with monoclonal antibodies. EMBO J 1984;3(10):2301-2306.
(75) Greenblatt CL, Meline D, Slutzky GM, Schnur LF, Levene C. Surface reaction of Leishmania. III. Ulex europaeus II lectin affinity for excreted factor (EF) serotype A strains. Ann Trop Med Parasitol 1984;78(2):99-107.
(76) El-On J, Messer G, Greenblatt CL. Growth inhibition of Leishmania tropica amastigotes in vitro by rifampicin combined with amphotericin B. Ann Trop Med Parasitol 1984;78(2):93-98.
(77) Zehavi U, Abrahams JC, Granoth R, Greenblatt CL, Slutzky GM, El-On J. Leishmanial excreted factors (EFs): Purification by affinity chromatography. Z Parasitenkd 1983;69(6):695-701.
(78) Zehavi U, El-On J, Pearlman E, Abrahams JC, Greenblatt CL. Binding of Leishmania promastigotes to macrophages. Z Parasitenkd 1983;69(4):405-414.
(79) El-On J, Zehavi U, Avraham H, Greenblatt CL. Leishmania tropica and Leishmania donovani: Solid phase radioimmunoassay using leishmanial excreted factor. Exp Parasitol 1983;55(3):270-279.
(80) GREEN MS, KARK JD, GREENBLATT CL, LONDNER MV, FRANKENBURG S, JACOBSON RL. The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotes. Parasite Immunol 1983;5(4):337-344.
(81) Livshin R, El‐On J, Weinrauch L, Greenblatt CL, Even‐Paz Z. Therapeutic Effect of Rifampicin and Isoniazid against Leishmania tropica major. Int J Dermatol 1983;22(1):61-61.
(82) LONDNER MV, FRANKENBURG S, SLUTZKY GM, GREENBLATT CL. Action of leishmanial excreted factor (EF) on human lymphocyte blast transformation. Parasite Immunol 1983;5(3):249-256.
(83) El On J, Greenblatt CL. An in vitro model for testing the effect of anti-leishmanial drugs of possible use in topical treatment. Curr Ther Res Clin Exp 1983;33(4):660-669.
(84) Greenblatt CL, Slutzky GM, DeIbarra LAA, Snary D. Monoclonal antibodies for serotyping Leishmania strains. J Clin Microbiol 1983;18(1):191-193.
(85) El On J, Pearlman E, Schnur L, Greenblatt CL. Chemotherapeutic activity of rifampicin on leishmanial amastigotes and promastigotes in vitro. Isr J Med Sci 1983;19(3):240-245.
(86) Green MS, Kark JD, Witztum E, Greenblatt CL, Spira DT. Frozen stored Leishmania tropica vaccine: the effects of dose, route of administration and storage on the evolution of the clinical lesion. Two field trials in the Israel Defense Forces. Trans R Soc Trop Med Hyg 1983;77(2):152-159.
(87) Walter RD, Slutzky GM, Greenblatt CL. Effect of leishmanial excreted factor on the activities of adenylate cyclase from hamster liver and Leishmania tropica. Tropenmed Parasitol 1982;33(3):137-139.
(88) Bolla RI, Greenblatt C. Age-related changes in rat liver total protein and transferrin synthesis. Age 1982;5(3):72-79.
(89) Frankenburg S, Londner MV, Greenblatt CL. Cellular changes in bone marrow of malaria-infected mice - III. Chemotaxis of Granulocytes. Z Parasitenkd 1982;68(1):39-45.
(90) Millgram M, Greenblatt CL, Shlomai J, Kaback HR. The interaction of ionophores and aminoglycosides in the killing of Crithidia. J Protozool 1982;29(3):536.
(91) Jacobson RL, Schnur LF, Slutzky GM, Greenblatt CL, Doyle JJ. Surface reaction of Leishmania: II. Correlation between surface antigens and mixed serotypes. Ann Trop Med Parasitol 1982;76(5):521-525.
(92) Even‐Paz Z, Weinrauch L, Livshin R, El‐On J, Leonard Greenblatt C. Rifampicin Treatment of Cutaneous Leishmaniasis. Int J Dermatol 1982;21(2):110-112.
(93) Jacobson RL, Slutzky GM, Slutzky GM, Greenblatt CL, Schnur LF. Surface reaction of Leishmania: I. Lectin-mediated agglutination. Ann Trop Med Parasitol 1982;76(1):45-52.
(94) Slutzky GM, Greenblatt CL. Identification of galactose as the immunodominant sugar of leishmanial excreted factor and subsequent labeling with galactose oxidase and sodium boro[3H]hydride. Infect Immun 1982;37(1):10-14.
(95) Bachrach U, Abu-Elheiga L, Talmi M, Schnur LF, El-On J, Greenblatt CL. Polyamines and the growth of leishmanial parasites. Med Biol 1981;59(5-6):441-447.
(96) Londner MV, Frankenburg S, Tyroler E, Greenblatt CL. Adoptive transfer of immunity to Plasmodium berghei after busulfan and cyclophosphamide treatment of recipient mice. Z Parasitenkd 1981;65(2):163-166.
(97) Greenblatt C, Kark J, Schnur L, Slutzky G. DO LEISHMANIA SEROTYPES MIMIC HUMAN BLOOD GROUP ANTIGENS? Lancet 1981;317(8218):505-506.
(98) Dishon T, Slutzky GM, El-On J, Greenblatt CL. Coagglutination and indirect hemagglutination in the detection of an excreted immunologically active substance from Leishmania. Isr J Med Sci 1981;17(4):245-248.
(99) Bachrach U, Schnur LF, El-On J, Greenblatt CL, Pearlman E, Robert-Gero M, et al. Inhibitory activity of sinefungin and siba (5′-deoxy-5′-S-isobutylthio-adenosine) on the growth of promastigotes and amastigotes of different species of leishmania. FEBS Lett 1980;121(2):287-291.
(100) Greenblatt CL. The present and future of vaccination for cutaneous leishmaniasis. Prog Clin Biol Res 1980;47:259-285.
(101) Greenblatt CL, Spira DT, Montilio B, Gerichter H. An improved protocol for the preparation of a frozen promastigote vaccine for cutaneous leishmaniasis. J Biol Stand 1980;8(3):227-232.
(102) Hernandez AG, Rodriguez N, Dagger F, Greenblatt CL. Production and secretion of Leishmania braziliensis proteins. Mol Biochem Parasitol 1980;1(3):143-149.
(103) Frankenburg S, Londner MV, Greenblatt CL. Cellular changes in the bone marrow of Plasmodium berghei-infected mice: II. Blast transformation and phagocytosis. Cell Immunol 1980;55(1):185-190.
(104) Witztum E, Greenblatt CL, Kark J, Spira DT, Koufman Z, Michaeli D. Development of a storable Leishmania tropica vaccine: Field testing with frozen promastigotes. Isr J Med Sci 1979;15(9):749-753.
(105) Schnur LF, Bachrach U, Greenblatt CL, Ben Joseph M. Polyamine synthesis and levels during the growth and replication of Leishmania tropica minor and Leishmania aethiopica. FEBS Lett 1979;106(1):202-206.
(106) Slutzky GM, El-On J, Greenblatt CL. Leishmanial excreted factor: Protein-bound and free forms from promastigote cultures of Leishmania tropica and Leishmania donovani. Infect Immun 1979;26(3):916-924.
(107) Bachrach U, Brem S, Wertman SB, Schnur LF, Greenblatt CL. Leishmania spp.: Effect of inhibitors on growth and on polyamine and macromolecular syntheses. Exp Parasitol 1979;48(3):464-470.
(108) Bachrach U, Brem S, Wertman SB, Schnur LF, Greenblatt CL. Leishmania spp.: Cellular levels and synthesis of polyamines during growth cycles. Exp Parasitol 1979;48(3):457-463.
(109) Slutzky GM, Greenblatt CL. Analysis by SDS-polyacrylamide gel electrophoresis of an immunologically active factor of Leishmania tropica from growth media, promastigotes, and infected macrophages. Biochem Med 1979;21(1):70-77.
(110) El-On J, Schnur LF, Greenblatt CL. Leishmania donovani: Physicochemical, immunological, and biological characterization of excreted factor from promastigotes. Exp Parasitol 1979;47(2):254-269.
(111) Koufman Z, Egoz N, Greenblatt CL, Handman E, Montilio B, Even-Paz Z. Observations on immunization against cutaneous leishmaniasis in Israel. Isr J Med Sci 1978;14(2):218-222.
(112) Jacobson RL, Zuckerman A, Greenblatt CL. Plasmodium berghei adoptive transfer and immunosuppression of immunity in allogenic neonates. Clin Exp Immunol 1978;33(1):25-29.
(113) Greenblatt CL, Cohen S, Brown KN, Meuwissen HE, Osunkoya BO, Spira DT. Summing up of the symposium: immunology and immunopathology of malaria. Isr J Med Sci 1978;14(6):712-717.
(114) Frankenburg S, Greenblatt CL. Cellular changes in the bone marrow of Plasmodium berghei infected mice. Isr J Med Sci 1978;14(5):582-589.
(115) Greenblatt CL, Jacobson RL. Speculation on the use of adoptive immunity in malarial vaccination. Isr J Med Sci 1978;14(5):596-598.
(116) Greenblatt CL. Historical trends in the antimalarial campaign in Palestine and Israel. Isr J Med Sci 1978;14(5):508-517.
(117) Slutzky GM, Greenblatt CL. Isolation of a carbohydrate-rich immunologically active factor from cultures of Leishmania tropica. FEBS Lett 1977;80(2):401-404.
(118) Handman E, Greenblatt CL. Promotion of leishmanial infections in non-permissive host macrophages by conditioned medium. Z Parasitenk 1977;53(2):143-147.
(119) Frankenburg S, Greenblatt CL, Golenser J, Spira DT. Plasmodium berghei: Relationship between mitosis and erythropoiesis in spleen cells of infected rats. Exp Parasitol 1977;43(2):362-369.
(120) El-On J, Greenblatt CL. Trypanosoma lewisi, T. acomys and T. cruzi: A method for their cultivation with mammalian tissue. Exp Parasitol 1977;41(1):31-42.
(121) Greenblatt CL. Nutritional and immunological factors in the control of infections with Trypanosoma lewisi. Exp Parasitol 1975;38(3):342-349.
(122) Greenblatt CL, Yoffey JM. Trypanosoma lewisi: Immunohematopoietic interrelationships of the infection in normal, hypoxic, and rebound animals. Exp Parasitol 1975;38(1):105-112.
(123) Greenblatt CL. Trypanosoma lewisi: Electron microscopy of the infected spleen. Exp Parasitol 1973;34(2):197-210.
(124) Sharpless NE, Greenblatt CL, Jennings WH. Therapeutic interference studies: mechanisms of interpolymer competition for dyes. Trans N Y Acad Sci 1973;35(3):187-195.
(125) Schnur LF, Zuckerman A, Greenblatt CL. Leishmanial serotypes as distinguished by the gel diffusion of factors excreted in vitro and in vivo. Isr J Med Sci 1972;8(7):932-942.
(126) Greenblatt CL, Spira DT, Tyroler E. Trypanosoma lewisi: Immune spleen cell transfer in rats. Exp Parasitol 1972;32(1):131-139.
(127) el-On J, Greenblatt CL. The effect of the immunosuppressive agent cyclophosphamide on IgG levels and parasite number in experimental trypanosomiasis. Isr J Med Sci 1971;7(11):1294-1298.
(128) Greenblatt CL, Tyroler E. Trypanosoma lewisi: In vitro behavior of rat spleen cells. Exp Parasitol 1971;30(3):363-374.
(129) Greenblatt CL, Sharpless NE, Yamaoka K. Competition for polymeric binding sites between acridine and triphenylmethane dyes. Mol Pharmacol 1970;6(6):649-658.
(130) Sharpless NE, Greenblatt CL. Influence of structural factors in the acridines upon their therapeutic effectiveness. Quantum mechanical parameters. Exp Parasitol 1969;24(2):216-227.
(131) Sharpless NE, Greenblatt CL. Interactions between acridines and triphenyl methane dyes: Their possible role in therapeutic interference. Exp Parasitol 1969;24(2):205-215.
(132) Greenblatt CL, Jori LA, Cahnmann HJ. Chromatographic separation of a rat serum growth factor required by Trypanosoma lewisi. Exp Parasitol 1969;24(2):228-242.
(133) Greenblatt CL, Shelton E. Mouse serum as an environment for the growth of Trypanosoma lewisi. Exp Parasitol 1968;22(2):187-200.
(134) Park HD, Greenblatt CL, Mattern CFT, Merril CR. Some relationships between Chlorohydra, its symbionts and some other chlorophyllous forms. J Exp Zool 1967;164(2):141-161.
(135) GREENBLATT CL, WETZEL BK. Alterations in Fatty Acid Metabolism and Morphology of Leishmania enriettii Exposed to Elevated Temperature. J Protozool 1966;13(4):521-531.
(136) Buy HGd, Greenblatt CL, Hayes Jr. JE, Lincicome DR. Regulation of cell membrane permeability in Trypanosoma lewisi. Exp Parasitol 1966;18(2):231-243.
(137) Greenblatt CL, Lincicome DR. Identity of trypanosome growth factors in serum II. Active globulin components. Exp Parasitol 1966;19(2):139-150.
(138) KORN ED, GREENBLATT CL, LEES AM. SYNTHESIS OF UNSATURATED FATTY ACIDS IN THE SLIME MOLD PHYSARUM. J Lipid Res 1965;6:43-50.
(139) Greenblatt CL, Glaser P. Temperature effect on Leishmania enriettii in vitro. Exp Parasitol 1965;16(1):36-52.
(140) Korn ED, Greenblatt CL. Synthesis of α-linolenic acid by leishmania enriettii. Science 1963;142(3597):1303-1304.
(141) Trejos A, Godoy GA, Greenblatt C, Cedillos R. Effects of temperature on morphologic variation of Schizotrypanum cruzi in tissue culture. Exp Parasitol 1963;13(2):211-218.
(142) KORN ED, GREENBLATT CL. SYNTHESIS OF ALPHA-LINOLENIC ACID BY LEISHMANIA ENRIETTII. Science 1963;142:1301-1303.
(143) Mantel N, Greenblatt CL. Excessive variation in radiation-induced chromosome aberrations. Nature 1962;193(4817):795-796.
(144) Greenblatt CL. The evaluation of x-ray-induced chromosome aberrations in cell-cultures of the chinese hamster. Int J Radiat Biol 1961;4(2):185-210.
(145) GREENBLATT CL, OLSON RA, ENGEL EK. Absorption microscopy of enzymatically treated cell-free chloroplasts. J Biophys Biochem Cytol 1960;7:235-238.
(146) GREENBLATT CL, SHARPLESS NE. Effects of Some Metabolic Inhibitors on the Pigments of Euglena gracilis in an Acidic Medium. J Protozool 1959;6(3):241-248.
(147) GREENBLATT CL, SCHIFF JA. A Pheophytin‐like Pigment in Dark‐Adapted Euglena gracilis. J Protozool 1959;6(1):23-28.
(148) GREENBLATT CL, SHARPLESS NE. Addendum to: Effects of metabolic inhibitors on pigments of Euglena. J Protozool 1959;6(4):319-319.
(149) WOLKEN JJ, MELLON AD, GREENBLATT CL. Environmental Factors Affecting Growth and Chlorophyll Synthesis in Euglena. I. Physical and Chemical. II. The Effectiveness of the Spectrum for Chlorophyll Synthesis. J Protozool 1955;2(3):89-96.